Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study
暂无分享，去创建一个
E. Mejstrikova | A. Órfão | J. V. van Dongen | V. V. D. van der Velden | J. Flores-Montero | J. Philippé | M. Szczepanowski | S. Nierkens | T. Szczepański | L. Sędek | S. Barrena | M. Brüggemann | G. Gaipa | M. Nováková | C. Buracchi | Elen Oliveira | A. Laqua | M. Hofmans | J. Kulis | Martijn W. C. Verbeek | S. Kohlscheen | A. de Jong | Elaine Sobral de Costa | R. Jugooa